DK2747551T3 - Fumarylacetoacetate-hydrolase (FAH)-deficiente og immundeficiente rotter og anvendelser deraf - Google Patents
Fumarylacetoacetate-hydrolase (FAH)-deficiente og immundeficiente rotter og anvendelser deraf Download PDFInfo
- Publication number
- DK2747551T3 DK2747551T3 DK12828793.5T DK12828793T DK2747551T3 DK 2747551 T3 DK2747551 T3 DK 2747551T3 DK 12828793 T DK12828793 T DK 12828793T DK 2747551 T3 DK2747551 T3 DK 2747551T3
- Authority
- DK
- Denmark
- Prior art keywords
- fah
- deficient
- fumarylacetoacetate hydrolase
- immunodeficient rats
- immunodeficient
- Prior art date
Links
- 102100029115 Fumarylacetoacetase Human genes 0.000 title 2
- 108010022687 fumarylacetoacetase Proteins 0.000 title 2
- 241000700159 Rattus Species 0.000 title 1
- 230000002950 deficient Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0276—Knock-out vertebrates
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6456—Plasminogen activators
- C12N9/6462—Plasminogen activators u-Plasminogen activator (3.4.21.73), i.e. urokinase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21073—Serine endopeptidases (3.4.21) u-Plasminogen activator (3.4.21.73), i.e. urokinase
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/12—Animals modified by administration of exogenous cells
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/15—Humanized animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/035—Animal model for multifactorial diseases
- A01K2267/0387—Animal model for diseases of the immune system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y307/00—Hydrolases acting on carbon-carbon bonds (3.7)
- C12Y307/01—Hydrolases acting on carbon-carbon bonds (3.7) in ketonic substances (3.7.1)
- C12Y307/01002—Fumarylacetoacetase (3.7.1.2)
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Environmental Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161527865P | 2011-08-26 | 2011-08-26 | |
| PCT/US2012/052306 WO2013032918A1 (en) | 2011-08-26 | 2012-08-24 | Fumarylacetoacetate hydrolase (fah)-deficient and immunodeficient rats and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2747551T3 true DK2747551T3 (da) | 2020-05-18 |
Family
ID=47756758
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK12828793.5T DK2747551T3 (da) | 2011-08-26 | 2012-08-24 | Fumarylacetoacetate-hydrolase (FAH)-deficiente og immundeficiente rotter og anvendelser deraf |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US20140373187A1 (da) |
| EP (2) | EP3578042A1 (da) |
| JP (2) | JP6484444B2 (da) |
| CY (1) | CY1122857T1 (da) |
| DK (1) | DK2747551T3 (da) |
| ES (1) | ES2791829T3 (da) |
| PL (1) | PL2747551T3 (da) |
| WO (1) | WO2013032918A1 (da) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2449112A1 (en) | 2009-07-01 | 2012-05-09 | Transposagen Biopharmaceuticals, Inc. | Genetically modified rat models for severe combined immunodeficiency (scid) |
| WO2013032918A1 (en) * | 2011-08-26 | 2013-03-07 | Yecuris Corporation | Fumarylacetoacetate hydrolase (fah)-deficient and immunodeficient rats and uses thereof |
| WO2013096955A1 (en) * | 2011-12-23 | 2013-06-27 | Case Western Reserve University | Targeted gene modification using hybrid recombinant adeno-associated virus |
| MX2015010841A (es) | 2013-02-20 | 2016-05-09 | Regeneron Pharma | Modificacion genetica de ratas. |
| SI2986729T1 (sl) | 2013-04-16 | 2019-02-28 | Regeneron Pharmaceuticals, Inc. | Ciljana sprememba genoma podgane |
| KR102658190B1 (ko) * | 2015-04-13 | 2024-04-17 | 리제너론 파마슈티칼스 인코포레이티드 | 인간화된 sirpa-il15 녹인 마우스 및 이의 이용 방법 |
| US11716974B2 (en) * | 2016-06-27 | 2023-08-08 | Baylor College Of Medicine | Human liver chimeric mouse with deficient P450 oxidoreductase |
| EP3497230A1 (en) * | 2016-08-15 | 2019-06-19 | Danmarks Tekniske Universitet | Method for reducing ammonium and lactate production in cho cells |
| EP3583201B1 (en) * | 2017-02-14 | 2024-01-17 | University of Pittsburgh - Of the Commonwealth System of Higher Education | Methods of engineering human induced pluripotent stem cells to produce liver tissue |
| WO2018228534A1 (zh) * | 2017-06-16 | 2018-12-20 | 中国科学院上海生命科学研究院 | 制备免疫缺陷的大鼠的方法及其应用 |
| KR20220035926A (ko) * | 2019-07-26 | 2022-03-22 | 앰비스 메디신즈 인코포레이티드 | 간세포 생성을 위한 방법 및 조성물 |
| CN113440502B (zh) * | 2020-11-30 | 2022-10-18 | 先见明创医药科技(苏州)有限公司 | Fah基因缺失动物的程序化慢性肝损伤维持及其在制备异源化肝脏模型中的应用 |
| CA3238170A1 (en) * | 2021-11-12 | 2023-05-19 | Cytotheryx, Inc. | Methods of producing and using human hepatocytes and related compositions |
| IL318159A (en) | 2022-07-19 | 2025-03-01 | Regeneron Pharma | Genetically modified animal model and its use to model the human immune system |
| WO2024073679A1 (en) | 2022-09-29 | 2024-04-04 | Regeneron Pharmaceuticals, Inc. | Correction of hepatosteatosis in humanized liver animals through restoration of il6/il6r/gp130 signaling in human hepatocytes |
| WO2025250495A1 (en) | 2024-05-28 | 2025-12-04 | Regeneron Pharmaceuticals, Inc. | Acceleration of human hepatocyte engraftment in humanized liver animals by supplementing paracrine ligands or agonists that activate human liver regeneration signals |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6484444A (en) | 1987-09-25 | 1989-03-29 | Sony Corp | Two-shaft driving device for optical pickup |
| US5585362A (en) | 1989-08-22 | 1996-12-17 | The Regents Of The University Of Michigan | Adenovirus vectors for gene therapy |
| US5061620A (en) | 1990-03-30 | 1991-10-29 | Systemix, Inc. | Human hematopoietic stem cell |
| US5173414A (en) | 1990-10-30 | 1992-12-22 | Applied Immune Sciences, Inc. | Production of recombinant adeno-associated virus vectors |
| US5980886A (en) | 1994-12-14 | 1999-11-09 | University Of Washington | Recombinant vectors for reconstitution of liver |
| US5843780A (en) | 1995-01-20 | 1998-12-01 | Wisconsin Alumni Research Foundation | Primate embryonic stem cells |
| DE19525900C1 (de) | 1995-07-15 | 1996-12-12 | Max Planck Gesellschaft | Leberspezifischer Adenovirus-Expressionsvektor |
| US5795711A (en) | 1996-04-04 | 1998-08-18 | Circe Biomedical, Inc. | Cryopreserved hepatocytes and high viability and metabolic activity |
| US6521225B1 (en) | 1996-09-06 | 2003-02-18 | Chiron Corporation | AAV vectors |
| AU6156399A (en) | 1998-09-18 | 2000-04-10 | Albert Einstein College Of Medicine Of Yeshiva University | Upa/rag-2 mouse with mammalian repopulating hepatocytes for infection by hepadnaviruses |
| US6995299B2 (en) | 1999-11-02 | 2006-02-07 | University Of Connecticut | Propagation of human hepatocytes in non-human animals |
| US6509514B1 (en) | 2000-03-17 | 2003-01-21 | Kmt Hepatech, Inc. | Chimeric animal model susceptible to human hepatitis C virus infection |
| MXPA00011713A (es) | 2000-11-28 | 2002-05-31 | Tgt Lab S A De C V | Vectores recombinantes virales y no virales conteniendo el gen humano del activador de plasminogeno derivado de urocinasa y su utilidad en el tratamiento de diversos tipos de fibrosis hepatica, renal, pulmonar, pancreatica, cardiaca y cicatrices hipe |
| AU2003228383A1 (en) | 2002-04-09 | 2003-10-27 | Global Biotech Inc. | Human tissue urokinase type plasminogen activator production |
| JP4237449B2 (ja) | 2002-06-05 | 2009-03-11 | 国立医薬品食品衛生研究所長 | アデノウィルスベクター |
| SG155053A1 (en) | 2002-07-19 | 2009-09-30 | Vesta Therapeutics Inc | Method of obtaining viable human liver cells, including hepatic stem/progenitor cells |
| KR20060067974A (ko) | 2003-09-19 | 2006-06-20 | 뉴사우스 이노베이션즈 피티와이 리미티드 | 간세포의 분리 방법 |
| EP1552740A1 (en) | 2004-01-09 | 2005-07-13 | Institut Pasteur | Chimeric murine model comprising human hepatocytes - use for screening compounds |
| US20080313748A1 (en) | 2004-09-03 | 2008-12-18 | Regents Of The University Of California | Transgenic Non-Human Animals Comprising the Human Udp-Glucuronosyltransferase 1A (Ugt1a) Gene Locus and Methods of Using Them |
| WO2006090724A1 (ja) * | 2005-02-23 | 2006-08-31 | Shionogi & Co., Ltd. | 変異型trpv3遺伝子導入トランスジェニックマウス又はトランスジェニックラット |
| WO2006135899A2 (en) | 2005-06-13 | 2006-12-21 | The Johns Hopkins University | Survival, differentiation and structural intergration of human neural stem cells grafted into the adult spinal cord |
| WO2007022419A2 (en) | 2005-08-17 | 2007-02-22 | Gene Logic, Inc. | Molecular toxicity models from isolated hepatocytes |
| US7588772B2 (en) | 2006-03-30 | 2009-09-15 | Board Of Trustees Of The Leland Stamford Junior University | AAV capsid library and AAV capsid proteins |
| JP5497639B2 (ja) * | 2007-06-05 | 2014-05-21 | オレゴン ヘルス アンド サイエンス ユニバーシティ | 生体内でヒト肝細胞を増大させる方法 |
| US20110030072A1 (en) * | 2008-12-04 | 2011-02-03 | Sigma-Aldrich Co. | Genome editing of immunodeficiency genes in animals |
| US20120045764A1 (en) | 2009-05-01 | 2012-02-23 | Markus Grompe | Method of expanding human hepatocytes in vivo |
| EP2449112A1 (en) | 2009-07-01 | 2012-05-09 | Transposagen Biopharmaceuticals, Inc. | Genetically modified rat models for severe combined immunodeficiency (scid) |
| JP5841322B2 (ja) * | 2010-04-22 | 2016-01-13 | オレゴン ヘルス アンド サイエンス ユニバーシティ | フマリルアセト酢酸ヒドロラーゼ(fah)欠損性ブタおよびその使用 |
| WO2013032918A1 (en) | 2011-08-26 | 2013-03-07 | Yecuris Corporation | Fumarylacetoacetate hydrolase (fah)-deficient and immunodeficient rats and uses thereof |
-
2012
- 2012-08-24 WO PCT/US2012/052306 patent/WO2013032918A1/en not_active Ceased
- 2012-08-24 JP JP2014527330A patent/JP6484444B2/ja active Active
- 2012-08-24 US US14/241,316 patent/US20140373187A1/en not_active Abandoned
- 2012-08-24 DK DK12828793.5T patent/DK2747551T3/da active
- 2012-08-24 ES ES12828793T patent/ES2791829T3/es active Active
- 2012-08-24 EP EP19172883.1A patent/EP3578042A1/en not_active Withdrawn
- 2012-08-24 PL PL12828793T patent/PL2747551T3/pl unknown
- 2012-08-24 EP EP12828793.5A patent/EP2747551B1/en active Active
-
2016
- 2016-05-19 US US15/159,200 patent/US10470445B2/en active Active
-
2017
- 2017-02-13 JP JP2017024322A patent/JP6573924B2/ja active Active
-
2019
- 2019-08-30 US US16/557,155 patent/US11793178B2/en active Active
-
2020
- 2020-05-12 CY CY20201100435T patent/CY1122857T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20200008406A1 (en) | 2020-01-09 |
| JP6484444B2 (ja) | 2019-03-13 |
| US20140373187A1 (en) | 2014-12-18 |
| EP2747551A4 (en) | 2015-07-15 |
| JP6573924B2 (ja) | 2019-09-11 |
| US11793178B2 (en) | 2023-10-24 |
| CY1122857T1 (el) | 2021-05-05 |
| JP2017131227A (ja) | 2017-08-03 |
| PL2747551T3 (pl) | 2020-09-21 |
| EP2747551B1 (en) | 2020-02-12 |
| WO2013032918A1 (en) | 2013-03-07 |
| EP2747551A1 (en) | 2014-07-02 |
| US20160249591A1 (en) | 2016-09-01 |
| JP2014525248A (ja) | 2014-09-29 |
| ES2791829T3 (es) | 2020-11-06 |
| EP3578042A1 (en) | 2019-12-11 |
| US10470445B2 (en) | 2019-11-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2747551T3 (da) | Fumarylacetoacetate-hydrolase (FAH)-deficiente og immundeficiente rotter og anvendelser deraf | |
| FR21C1061I2 (fr) | Anticorps anti-angptl3 et utilisations de ceux-ci | |
| BR112013010185A2 (pt) | composições pesticidas e processos relacionados às mesmas | |
| CO6870049A2 (es) | Composiciones plaguicidas y procesos relacionados | |
| CO6940439A2 (es) | Composiciones plaguicidas y procesos relacionados con dichas composiciones | |
| CL2013001228A1 (es) | Composiciones plaguicidas y procesos relacionados con dichas composiciones | |
| BR112013006293A2 (pt) | arilpirrolidinas pesticidas | |
| CL2014002899A1 (es) | Composiciones pesticidas y procesos relacionados con ellas | |
| LT2780375T (lt) | Bcma ir cd3 prijungiančios molekulės | |
| LT2675827T (lt) | Nauji moduliatoriai ir jų panaudojimo būdai | |
| CO6940438A2 (es) | Composiciones pesticidas y procesos relacionados con las mismas | |
| DK2755595T3 (da) | Anordninger til tandblegning | |
| BR112015003354A2 (pt) | composições e métodos de microcápsula | |
| IL232247A0 (en) | Polypeptide constructs and uses thereof | |
| BR112014031820A2 (pt) | aduto de politioéter e composição | |
| BR112013014665A2 (pt) | misturas pesticidas | |
| DK2571624T3 (da) | Multifysisk brændstofforstøver og fremgangsmåder | |
| BR112012024023A2 (pt) | Misturas pesticidas | |
| EP2873230A4 (en) | PICTURES ACCELERATOR | |
| BR112013016155A2 (pt) | filtro de combustível | |
| EP2699272A4 (en) | TARGETED CONTRASTING AGENTS AND USES THEREOF | |
| DE112011103920A5 (de) | Kraftstofffilter | |
| EP2793921A4 (en) | PEPTIDES DERIVED FROM SAPOSINE-A AND USES THEREOF | |
| ZA201208441B (en) | Rodent and insect repellent | |
| EP2844692A4 (en) | OXYGEN ABSORBING COMPOSITIONS |